ProStrakan is a rapidly growing specialty pharmaceutical company engaged in the development and commercialisation of prescription medicines for the treatment of unmet therapeutic needs in major markets.

ProStrakan Group PLC is owned by Kyowa Hakko Kirin Co., Ltd (KHK) of Japan and is one of Europe’s fastest growing specialty pharmaceutical companies. With more than 300 people employed by the Company, ProStrakan is headquartered in Scotland with commercial operations throughout the rest of the UK and continental Europe and a US head office. The Company's Development group is located in Galashiels, Scotland and Bridgewater, New Jersey, US.

We market a range of specialist products through our commercial operations based in the UK, US, Germany, France, Italy, Spain and Sweden.

In addition to our links with our parent company, KHK, ProStrakan has a network of partners who distribute our products in other territories around the world.

ProStrakan was established in Galashiels in the Scottish Borders in 1995. 35 miles South of Scotland’s capital city, Edinburgh. Galashiels is an excellent location from which to build an international pharmaceuticals company. Communications links are strong, with direct links to both Europe and the US out of Edinburgh Airport, and main arterial roads linking the town both North and South.